Evidence map›Paper›PMID 30305013›Full record

ArticleBMC genomics2018

Thirty biologically interpretable clusters of transcription factors distinguish cancer type.

Zachary B Abrams, Mark Zucker, Min Wang, Amir Asiaee Taheri, Lynne V Abruzzo, Kevin R Coombes

Abstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Transcriptome Complexity Disentangled: A Regulatory Molecules Approach.International journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. ETS-1/c-Met drives resistance to sorafenib in hepatocellular carcinoma.American journal of translational research · 2023
    Article
  7. Article
  8. Article
  9. Explaining Gene Expression Using Twenty-One MicroRNAs.Journal of computational biology : a journal of computational molecular cell biology · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zachary B AbramsDepartment of Biomedical Informatics, The Ohio State University, 1800 Cannon Drive, Columbus, 43210, OH, USA.
Mark ZuckerDepartment of Biomedical Informatics, The Ohio State University, 1800 Cannon Drive, Columbus, 43210, OH, USA.
Min WangDepartment of Biomedical Informatics, The Ohio State University, 1800 Cannon Drive, Columbus, 43210, OH, USA.
Amir Asiaee TaheriDepartment of Biomedical Informatics, The Ohio State University, 1800 Cannon Drive, Columbus, 43210, OH, USA.
Lynne V AbruzzoDepartment of Pathology, The Ohio State University, 129 Hamilton Hall, 1645 Neil Avenue, Columbus, 43210, OH, USA.
Kevin R CoombesDepartment of Biomedical Informatics, The Ohio State University, 1800 Cannon Drive, Columbus, 43210, OH, USA. coombes.3@osu.edu.ORCID http://orcid.org/0000-0002-7630-2123

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Daniel G. Stover · 1985 to 2026
$132.3M
UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V. · 1996 to 2024
$57.4M
The Ohio State University and MD Anderson Cancer Center Thyroid Cancer SPOREP50CA168505 · NCI · OHIO STATE UNIVERSITY · PI DE LA CHAPELLE, ALBERT · 2013 to 2017
$10.9M
Protein-coding and non-coding RNA biomarkers for early detection of CLLR01CA182905 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABRUZZO, LYNNE V., CALIN, GEORGE A. · 2014 to 2018
$2.9M
The OSU Clinical and Translational Research Informatics Training Program (CTRIP)T15LM011270 · NLM · OHIO STATE UNIVERSITY · PI COOMBES, KEVIN ROBERT, JANIES, DANIEL A. · 2012 to 2016
$2.2M
National Cancer Institute P50 CA016508National Cancer Institute P50 CA070907National Cancer Institute P50 CA168505National Cancer Institute R01 CA182905NCI NIH HHS P30 CA016058NCI NIH HHS P50 CA070907NCI NIH HHS P50 CA168505NCI NIH HHS R01 CA182905NLM NIH HHS T15 LM011270U.S. National Library of Medicine T15 LM011270
6 · The paper itself

Abstract

backgroundTranscription factors are essential regulators of gene expression and play critical roles in development, differentiation, and in many cancers. To carry out their regulatory programs, they must cooperate in networks and bind simultaneously to sites in promoter or enhancer regions of genes. We hypothesize that the mRNA co-expression patterns of transcription factors can be used both to learn how they cooperate in networks and to distinguish between cancer types.

resultsWe recently developed a new algorithm, Thresher, that combines principal component analysis, outlier filtering, and von Mises-Fisher mixture models to cluster genes (in this case, transcription factors) based on expression, determining the optimal number of clusters in the process. We applied Thresher to the RNA-Seq expression data of 486 transcription factors from more than 10,000 samples of 33 kinds of cancer studied in The Cancer Genome Atlas (TCGA). We found that 30 clusters of transcription factors from a 29-dimensional principal component space were able to distinguish between most cancer types, and could separate tumor samples from normal controls. Moreover, each cluster of transcription factors could be either (i) linked to a tissue-specific expression pattern or (ii) associated with a fundamental biological process such as cell cycle, angiogenesis, apoptosis, or cytoskeleton. Clusters of the second type were more likely also to be associated with embryonically lethal mouse phenotypes.

conclusionsUsing our approach, we have shown that the mRNA expression patterns of transcription factors contain most of the information needed to distinguish different cancer types. The Thresher method is capable of discovering biologically interpretable clusters of genes. It can potentially be applied to other gene sets, such as signaling pathways, to decompose them into simpler, yet biologically meaningful, components.

Indexed as

Computational BiologyCluster AnalysisGene Expression ProfilingNeoplasmsPrincipal Component AnalysisTranscription FactorsTranscription FactorsClusteringGene expressionPan-cancerTCGAThresher

Identifiers

PMID30305013
PMCPMC6180590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.